Skip to content
Screener

Total Equity at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$4.66B+24.2%
Mannkind logo
MannkindMNKD
-$67.2M-22.1%
United Therapeutics logo
United TherapeuticsUTHR
$6.4B-10.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$10.42M-104%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$290.59M+75.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$2.28B-38.2%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock — 10,000,000 shares authorized, none outstanding
Common stock — $0.001 par value, 115,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively, 88,308,411 and 87,204,137 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively8887
Additional paid-in capital681,942670,974
Accumulated deficit(573,451)(626,313)
Total stockholders’ equity108,57944,748
Total liabilities and stockholders’ equity$401,533$327,934

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's total equity?
Liquidia Corporation (LQDA) reported total equity of $108.58M in Q1 2026.
How has Liquidia Corporation's total equity changed year-over-year?
Liquidia Corporation's total equity increased by 118.4% year-over-year, from $49.71M to $108.58M.
What is the long-term trend for Liquidia Corporation's total equity?
Over 5 years (2020 to 2025), Liquidia Corporation's total equity has grown at a -8.8% compound annual growth rate (CAGR), from $71.09M to $44.75M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Liquidia Corporation's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude